Á lódáil...
Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis
New treatments, such as sipuleucel-T and androgen receptor- (AR-) directed therapies (enzalutamide (Enz) and abiraterone acetate (AA)), have emerged and been approved for the management of castration-resistant prostate cancer (CRPC). There are still debates over their efficacy and clinical benefits....
Na minha lista:
Foilsithe in: | J Immunol Res |
---|---|
Main Authors: | , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Hindawi Publishing Corporation
2016
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5183769/ https://ncbi.nlm.nih.gov/pubmed/28058266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4543861 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|